CAS: 520-77-4; 3-Ethyl-5,5-Dimethyl-1,3-Oxazolidine-2,4-Dione
该化合物是在治疗某些心血管病方面,具有相关性;该化合物通常以白色为白,在白晶状固体中呈色,在有机溶剂中溶解;其行动机制涉及抑制维生素K-过氧化再生酶,这对肝脏凝聚因素合成至关重要;乙二氮的药用植物素包括口服生物利用率,在肝脏中代谢,其影响取决于剂量;安全性和毒性特征是基本考虑因素,与任何抗凝固剂一样,以防止诸如出血并发症等不利影响;
- 英文名称3-Ethyl-5,5-Dimethyl-1,3-Oxazolidine-2,4-Dione
- 中文名称依沙双酮
- IUPAC名称2,4-Oxazolidinedione, 3-ethyl-5,5-dimethyl- (8CI)(9CI)
- 其它别名3-Ethyl-5,5-dimethyl-2,4-diketooxazolidine; 3-Ethyl-5,5-dimethyl-2,4-oxazolidinedione; 3-Ethyl-5,5-dimethyl-2-oxo-4-oxazolidinone; Aethadion; Didione; Dimedion; Dimedione; Epinal; Epinyl; Ethadione; Ethadionum; Etydion; Neo-Absentol; Petidiol; Petidion; Petisan
- CAS编号520-77-4
- MFCD编号:MFCD00154758
- EINECS号:208-297-0
- FDA UNII编号:I0F8O700BB
- 分子式:C7H11NO3分子量:157.17
- 产品CID: 1511542
- 产品分类有机原料 → 有机杂环化合物 → 唑烷类
物理性质
MSDS等安全信息
欧盟法规
ECHA物质C&L通报REACH预注册上下游产品
CAS号6453-39-0 5,5-Dimethyl-2-... | CAS号695-53-4 二甲双酮 | CAS号64-67-5 硫酸二乙酯 | CAS号17994-46-6 3-ethyl-5,5-dim... | CAS号109-90-0 异氰酸乙酯 | CAS号80-55-7 2-羟基异丁酸乙酯 | CAS号75-03-6 碘乙烷 | CAS号54448-79-2 4-ethoxy-5,5-di...合成工艺路线路线简述
📜5,5-二甲基-2-硫代-1,3-恶唑烷-4-酮置于四氯化碳,乙醇,水,Sodium Ethanolate,氯体系中,化学反应生成 依沙双酮
参考文献:Davies Et Al.,Journal Of The Chemical Society,1950,P. 34
标题:Davies Et Al.,Journal Of The Chemical Society,1950,P. 34
海关参考信息
- 2905122000-异丙醇
2905143000-叔丁醇
2912110000-甲醛
2912120000-乙醛 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2008214827-A1
优先权日:2004-02-03
标 题:Synthesis of Cyanoimino-Benzoimidazoles
发明人：GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
权利人:EURO CELTIQUE SA
摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.
专利号:CA-2555219-A1
优先权日:2004-02-03
标 题 :Synthesis of cyanoimino-benzoimidazoles
专利号:US-8945508-B2
优先权日:2009-10-13
标 题 :Dendrimer compositions and methods of synthesis
发明人：BAKER JR JAMES R; HUANG BAOHUA
权利人:BAKER JR JAMES R; HUANG BAOHUA; UNIV MICHIGAN
摘要:The present invention relates to novel dendrimer compounds and methods of synthesizing the same. In particular, the present invention is directed to novel polyamidoamine (PAMAM) dendrimers, novel dendrimer branching units, methods for synthesizing such novel PAMAM dendrimers and functionalized dendrimers, as well as systems and methods utilizing the dendrimers (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease diagnosis and/or therapy, etc.))).
专利号:WO-2005075459-A1
优先权日:2004-02-03
标题:Synthesis of cyanoimino-benzoimidazoles
专利号:JP-2007520493-A
优先权日:2004-02-03
标 题 :Synthesis of cyanoiminobenzimidazole
专利号:EP-1711484-A4
优先权日:2004-02-03
标题:SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
主要参考文献
1: BERGSTRAND A, BERGSTRAND CG, ENGSTROM N, HERRLIN KM. Renal histology during treatment with oxazolidine-diones (trimethadione, ethadione, and paramethadione). Pediatrics. 1962 Oct;30:601-7. 60(3):485-91. doi: 10.1016/0041-008x(81)90335-5.
55:33-41. French.
12:859-63. French.
合成参考文献
参考文献:10.1186/1471-2458-11-370
摘要:Boehler CE, Milton KE, Bull FC, Fox-Rushby JA. The cost of changing physical activity behaviour: evidence from a "physical activity pathway" in the primary care setting. BMC Public Health. 2011 May 23;11():370.
📝 需求与反馈
尽可能描述清楚需求与问题信息
